☰

Kelly H. Skelton - Publications

Affiliations: 
Emory University, Atlanta, GA 
Area:
Psychiatry
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Wingo AP, Briscione M, Norrholm SD, Jovanovic T, McCullough SA, Skelton K, Bradley B. Psychological resilience is associated with more intact social functioning in veterans with post-traumatic stress disorder and depression. Psychiatry Research. 249: 206-211. PMID 28119173 DOI: 10.1016/J.Psychres.2017.01.022  0.316
2012 Skelton K, Ressler KJ, Norrholm SD, Jovanovic T, Bradley-Davino B. PTSD and gene variants: new pathways and new thinking. Neuropharmacology. 62: 628-37. PMID 21356219 DOI: 10.1016/J.Neuropharm.2011.02.013  0.317
2011 Ferdinand LG, Kelly UA, Skelton K, Stephens KJ, Bradley B. An evolving integrative treatment program for military sexual trauma (MST) and one veteran's experience. Issues in Mental Health Nursing. 32: 552-9. PMID 21859405 DOI: 10.3109/01612840.2011.582228  0.311
2007 Skelton KH, Oren D, Gutman DA, Easterling K, Holtzman SG, Nemeroff CB, Owens MJ. The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal. European Journal of Pharmacology. 571: 17-24. PMID 17610870 DOI: 10.1016/j.ejphar.2007.05.041  0.775
2007 Skelton KH, Gutman DA, Thrivikraman KV, Nemeroff CB, Owens MJ. The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal. Psychopharmacology. 192: 385-96. PMID 17297634 DOI: 10.1007/s00213-007-0713-3  0.781
2004 Skelton KH, Nemeroff CB, Owens MJ. Spontaneous withdrawal from the triazolobenzodiazepine alprazolam increases cortical corticotropin-releasing factor mRNA expression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 9303-12. PMID 15496666 DOI: 10.1523/JNEUROSCI.1737-04.2004  0.76
2003 Gilmor ML, Skelton KH, Nemeroff CB, Owens MJ. The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems. The Journal of Pharmacology and Experimental Therapeutics. 305: 434-9. PMID 12606697 DOI: 10.1124/jpet.102.045419  0.738
2003 Gutman DA, Owens MJ, Skelton KH, Thrivikraman KV, Nemeroff CB. The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress. The Journal of Pharmacology and Experimental Therapeutics. 304: 874-80. PMID 12538845 DOI: 10.1124/jpet.102.042788  0.745
2001 O'Brien D, Skelton KH, Owens MJ, Nemeroff CB. Are CRF receptor antagonists potential antidepressants? Human Psychopharmacology. 16: 81-87. PMID 12404602 DOI: 10.1002/hup.187  0.74
2001 O'Brien D, Skelton KH, Owens MJ, Nemeroff CB. Novel approaches to the treatment of depression by modulating the hypothalamic-pituitary-adrenal axis Human Psychopharmacology. 16: 89-93. DOI: 10.1002/hup.188  0.523
2000 Skelton KH, Owens MJ, Nemeroff CB. The neurobiology of urocortin. Regulatory Peptides. 93: 85-92. PMID 11033056 DOI: 10.1016/S0167-0115(00)00180-4  0.734
2000 Skelton KH, Nemeroff CB, Owens MJ. A comparison of plasma alprazolam concentrations following different routes of chronic administration in the Sprague-Dawley rat: implications for psychotropic drug research. Psychopharmacology. 151: 72-6. PMID 10958119 DOI: 10.1007/s002130000469  0.594
2000 Arborelius L, Skelton KH, Thrivikraman KV, Plotsky PM, Schulz DW, Owens MJ. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat. The Journal of Pharmacology and Experimental Therapeutics. 294: 588-97. PMID 10900236  0.778
2000 Skelton KH, Nemeroff CB, Knight DL, Owens MJ. Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 1240-8. PMID 10648728 DOI: 10.1523/Jneurosci.20-03-01240.2000  0.765
2000 Skelton KH, Nemeroff CB, Owens MJ. Urocortin, the CRF2 receptor and effects of anxiolytic drugs Psychoneuroendocrinology. 25: S17. DOI: 10.1016/S0306-4530(00)90091-X  0.771
2000 Nemeroff C, Owens M, Skelton K, Guttman D, Winslow J, Plotsky P. 210. CRF1 receptor antagonists as novel putative antidepressants and anxiolytics Biological Psychiatry. 47: S64. DOI: 10.1016/S0006-3223(00)00473-X  0.698
Show low-probability matches.